1. Home
  2. IRON vs AGBK Comparison

IRON vs AGBK Comparison

Compare IRON & AGBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$59.06

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

AGBK

AGI Inc Class A Common Shares

N/A

Current Price

$9.27

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
AGBK
Founded
2017
1999
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
AGBK
Price
$59.06
$9.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
5
Target Price
$103.18
$17.20
AVG Volume (30 Days)
520.9K
492.6K
Earning Date
05-06-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$283.52
$6.64
P/E Ratio
N/A
$46.19
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$8.66
52 Week High
$99.50
$12.21

Technical Indicators

Market Signals
Indicator
IRON
AGBK
Relative Strength Index (RSI) 39.24 37.01
Support Level $57.81 $9.00
Resistance Level $64.00 $10.11
Average True Range (ATR) 2.81 0.59
MACD 0.08 -0.15
Stochastic Oscillator 16.99 18.01

Price Performance

Historical Comparison
IRON
AGBK

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

Share on Social Networks: